Amicus Therapeutics to Announce Second Quarter 2025 Financial Results on July 31, 2025
Amicus Therapeutics (Nasdaq: FOLD), a global biotechnology company focused on rare diseases, will host a conference call and audio webcast on Thursday, July 31, 2025, at 8:30 a.m. ET to discuss its second quarter 2025 financial results.
Participants must pre-register online to receive dial-in details and a personal PIN for the call. A live webcast and presentation materials will be available through the Investors section at ir.amicusrx.com, with web participants encouraged to register 15 minutes before the call. An archived version of the webcast and slides will be available after the event.
Amicus Therapeutics (Nasdaq: FOLD), un'azienda biotecnologica globale specializzata nelle malattie rare, terrà una conference call e una webcasting audio giovedì 31 luglio 2025 alle 8:30 ET per discutere i risultati finanziari del secondo trimestre 2025.
I partecipanti devono registrarsi online in anticipo per ricevere i dettagli di accesso e un PIN personale per la chiamata. Una trasmissione in diretta e il materiale della presentazione saranno disponibili nella sezione Investitori su ir.amicusrx.com; si consiglia ai partecipanti online di registrarsi almeno 15 minuti prima dell'inizio della chiamata. Una versione registrata della webcasting e delle slide sarà disponibile dopo l'evento.
Amicus Therapeutics (Nasdaq: FOLD), una empresa biotecnológica global enfocada en enfermedades raras, realizará una llamada de conferencia y una transmisión de audio por internet el jueves 31 de julio de 2025 a las 8:30 a.m. ET para discutir los resultados financieros del segundo trimestre de 2025.
Los participantes deben registrarse en línea previamente para recibir los detalles de acceso y un PIN personal para la llamada. Una transmisión en vivo y los materiales de la presentación estarán disponibles en la sección de Inversores en ir.amicusrx.com; se recomienda a los participantes web registrarse 15 minutos antes de la llamada. Una versión archivada de la transmisión y las diapositivas estará disponible después del evento.
Amicus Therapeutics (Nasdaq: FOLD)는 희귀 질환에 중점을 둔 글로벌 생명공학 회사로, 2025년 7월 31일 목요일 오전 8시 30분(동부시간)에 2025년 2분기 재무 결과를 논의하기 위한 컨퍼런스 콜과 오디오 웹캐스트를 개최합니다.
참가자는 통화 접속 정보와 개인 PIN을 받기 위해 사전에 온라인 등록을 해야 합니다. 투자자 섹션 ir.amicusrx.com에서 생중계 웹캐스트와 발표 자료를 제공하며, 웹 참가자는 통화 15분 전에 등록하는 것이 권장됩니다. 이벤트 후에는 웹캐스트 및 슬라이드의 녹화본이 제공됩니다.
Amicus Therapeutics (Nasdaq : FOLD), une société biotechnologique mondiale spécialisée dans les maladies rares, organisera une conférence téléphonique et une diffusion audio en direct le jeudi 31 juillet 2025 à 8h30 ET pour discuter des résultats financiers du deuxième trimestre 2025.
Les participants doivent s'inscrire en ligne à l'avance pour recevoir les informations d'appel et un code PIN personnel. Une diffusion en direct et les documents de présentation seront disponibles dans la section Investisseurs sur ir.amicusrx.com ; il est conseillé aux participants en ligne de s'inscrire 15 minutes avant la conférence. Une version enregistrée de la diffusion et des diapositives sera accessible après l'événement.
Amicus Therapeutics (Nasdaq: FOLD), ein globales Biotechnologieunternehmen mit Fokus auf seltene Krankheiten, wird am Donnerstag, den 31. Juli 2025, um 8:30 Uhr ET eine Telefonkonferenz und einen Audio-Webcast abhalten, um die Finanzergebnisse des zweiten Quartals 2025 zu besprechen.
Teilnehmer müssen sich online vorregistrieren, um Einwahldaten und eine persönliche PIN für den Anruf zu erhalten. Ein Live-Webcast und Präsentationsmaterialien sind im Investor-Bereich unter ir.amicusrx.com verfügbar; Web-Teilnehmer werden gebeten, sich 15 Minuten vor Beginn der Konferenz anzumelden. Eine Aufzeichnung des Webcasts und der Folien wird nach der Veranstaltung bereitgestellt.
- None.
- None.
PRINCETON, N.J., July 21, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Thursday, July 31, 2025, at 8:30 a.m. ET to discuss financial results for the second quarter ended June 30, 2025.
Participants and investors interested in accessing the call by phone will need to register using the online registration form. After registering, all phone participants will receive a dial-in number along with a personal PIN to access the event. A live audio webcast and related presentation materials can also be accessed via the Investors section of the Amicus Therapeutics corporate website at ir.amicusrx.com. Web participants are encouraged to register on the website 15 minutes prior to the start of the call.
An archived webcast and accompanying slides will be available on the Company's website shortly after the conclusion of the live event.
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company’s website at www.amicusrx.com, and follow on X and LinkedIn.
CONTACT:
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Vice President, Corporate Communications
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FAQ
When is Amicus Therapeutics (FOLD) Q2 2025 earnings call?
How can investors join the Amicus Therapeutics Q2 2025 earnings call?
What period will Amicus Therapeutics Q2 2025 results cover?
Where can I find the replay of Amicus Therapeutics Q2 2025 earnings call?
